These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 15569430)
1. [Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance]. Jiang WJ; Liu TH; Chen J; Gao J; Wu SF; Chen YJ Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1705-9. PubMed ID: 15569430 [TBL] [Abstract][Full Text] [Related]
2. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors. Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325 [TBL] [Abstract][Full Text] [Related]
3. Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy. Yang YM; Liu TH; Chen YJ; Jiang WJ; Qian JM; Lu X; Gao J; Wu SF; Sang XT; Chen J Int J Cancer; 2005 Nov; 117(2):234-40. PubMed ID: 15900598 [TBL] [Abstract][Full Text] [Related]
4. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors. Guo SS; Wu AY; Sawicki MP World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210 [TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. D'Adda T; Keller G; Bordi C; Höfler H Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509 [TBL] [Abstract][Full Text] [Related]
6. A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications. Wild A; Langer P; Ramaswamy A; Chaloupka B; Bartsch DK J Clin Endocrinol Metab; 2001 Dec; 86(12):5782-7. PubMed ID: 11739439 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability. Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197 [TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance. Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732 [TBL] [Abstract][Full Text] [Related]
9. Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours. Nikiforova MN; Nikiforov YE; Biddinger P; Gnepp DR; Grosembacher LA; Wajchenberg BL; Fagin JA; Cohen RM Clin Endocrinol (Oxf); 1999 Jul; 51(1):27-33. PubMed ID: 10468962 [TBL] [Abstract][Full Text] [Related]
10. Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis. Jonkers YM; Claessen SM; Feuth T; van Kessel AG; Ramaekers FC; Veltman JA; Speel EJ J Pathol; 2006 Dec; 210(4):450-8. PubMed ID: 17068744 [TBL] [Abstract][Full Text] [Related]
12. Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors. Shan L; Nakamura Y; Nakamura M; Yokoi T; Tsujimoto M; Arima R; Kameya T; Kakudo K Lab Invest; 1998 Apr; 78(4):471-5. PubMed ID: 9564891 [TBL] [Abstract][Full Text] [Related]
13. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas. Hrasćan R; Pećina-Slaus N; Martić TN; Colić JF; Gall-Troselj K; Pavelić K; Karapandza N J Neuroendocrinol; 2008 Aug; 20(8):1015-22. PubMed ID: 18510707 [TBL] [Abstract][Full Text] [Related]
14. [Refined deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal carcinoma]. Zheng HT; Tang HM; Peng ZH; Zhou CZ; He L Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):157-60. PubMed ID: 16555160 [TBL] [Abstract][Full Text] [Related]
15. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth. Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671 [TBL] [Abstract][Full Text] [Related]
16. Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors. Ebrahimi SA; Wang EH; Wu A; Schreck RR; Passaro E; Sawicki MP Cancer Res; 1999 Jan; 59(2):311-5. PubMed ID: 9927038 [TBL] [Abstract][Full Text] [Related]
17. Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas. dos Reis PP; Poli-Frederico RC; dos Santos RM; Nishimoto IN; Kowalski LP; Rogatto SR Med Sci Monit; 2002 Mar; 8(3):BR89-94. PubMed ID: 11889455 [TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma. Zhou CZ; Peng ZH; Zhang F; Qiu GQ; He L World J Gastroenterol; 2002 Aug; 8(4):668-73. PubMed ID: 12174376 [TBL] [Abstract][Full Text] [Related]
19. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia. Anlauf M; Bauersfeld J; Raffel A; Koch CA; Henopp T; Alkatout I; Schmitt A; Weber A; Kruse ML; Braunstein S; Kaserer K; Brauckhoff M; Dralle H; Moch H; Heitz PU; Komminoth P; Knoefel WT; Perren A; Klöppel G Am J Surg Pathol; 2009 Mar; 33(3):339-46. PubMed ID: 19011561 [TBL] [Abstract][Full Text] [Related]
20. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas. Speel EJ; Scheidweiler AF; Zhao J; Matter C; Saremaslani P; Roth J; Heitz PU; Komminoth P Cancer Res; 2001 Jul; 61(13):5186-92. PubMed ID: 11431358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]